News

About 200 participants, including researchers, guests and interested members of the public, came together at media docs in Lübeck from 16 to 17 April to discuss the anonymization of personal data

At the DBT 2024, the InfectoGnostics research campus once again presented Thuringian technologies and products for the fields of biotechnology, diagnostics and medical technology.

Analysis and strategic realignment at the meeting in Cologne

The two Thuringian innovation clusters Medways and InfectoGnostics organized a joint stand for the first time in the Diagnostics Hall 3

From October 2 to 5, 2023, the State Development Agency of Thuringia (LEG) together with the InfectoGnostics Research Campus presented the Thuringian life sciences sector during a trip to Italy. The trip was supported by Germany Trade and Invest (GTAI) and organized by the Italian Chamber of…

The Hong Kong-based company Grande Bio-tech Co. Ltd. is making a multi-million Euros investment in the Jena-based diagnostic company Oncgnostics GmbH. Oncgnostics – an InfectoGnostics partner – has developed the cancer diagnostic Gyntect for the reliable detection of cervical cancer. The goal now is…

InfectoGnostics partner BLINK DX presented its new "Blink One" diagnostic platform in Anaheim, California, at the annual meeting of the American Association for Clinical Chemistry (AACC). The new platform enables very fast digital PCR (dPCR) in a few minutes without microfluidics and allows the…

Entrepreneurs from the innovative biotechnology sector entered into an exchange with politicians at the Unternehmer:innentag 2023 of BIO Deutschland e.V. in Berlin on July 5, 2023.

The facultatively pathogenic and often (multi-)resistant bacterium Staphylococcus aureus causes a large proportion of hospital infections worldwide. InfectoGnostics researchers from the Leibniz Institute for Photonic Technology (Leibniz-IPHT) were able to extensively molecularly characterize strains…

Organ-on-chip specialist Dynamic42 GmbH has closed a mid-seven-figure financing round. The company, which was spun off from the "Center of Sepsis Control and Care" of the University Hospital Jena in March 2018, was able to convince both the previous lead investor bm-t beteiligungsmanagement…